Login to your account

Username *
Password *
Remember Me
[PREPRINT] RCT | Inhaled fluticasone not beneficial for outpatients with Covid-19.

[PREPRINT] RCT | Inhaled fluticasone not beneficial for outpatients with Covid-19.

Inhaled Fluticasone for Outpatient Treatment of Covid-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial – medRxiv News Release: Study finds no benefit to taking fluticasone furoate for COVID-19 symptoms – Duke Clinical Research Institute Commentary: Asthma Drug Fluticasone Fails as Potential COVID-19 Treatment – HealthDay  

The post [PREPRINT] RCT | Inhaled fluticasone not beneficial for outpatients with Covid-19. appeared first on Links Medicus.

Lu 54 fois
Évaluer cet élément
(0 Votes)

About Author

Laissez un commentaire

Assurez-vous d'entrer toutes les informations requises, indiquées par un astérisque (*). Le code HTML n'est pas autorisé.